Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryszard Kole

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|August 20, 2003
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicingPeter Sazani, Ryszard Kole
Oligonucleotides|June 13, 2006
Analysis of prostate-specific membrane antigen splice variants in LNCap cellsTiffany Williams, Ryszard Kole
Bioengineered Bugs|June 4, 2011
Modulation of RNA splicing as a potential treatment for cancerJohn A Bauman, Ryszard Kole
Advanced Drug Delivery Reviews|May 19, 2015
Exon skipping therapy for Duchenne muscular dystrophyRyszard Kole, Arthur M Krieg
Discovery Medicine|August 1, 2012
Targeting mRNA splicing as a potential treatment for Duchenne muscular dystrophyRyszard Kole, Brian J Leppert
Biochimica Et Biophysica Acta|June 27, 2002
Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expressionDanielle R Mercatante, Ryszard Kole
Oligonucleotides|April 24, 2004
Modification of alternative splicing by antisense therapeuticsRyszard Kole, Marla Vacek, Tiffany Williams
International Journal of Cancer|November 28, 2008
Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cellsJing Wan, Peter Sazani, Ryszard Kole
Acta Biochimica Polonica|June 26, 2004
RNA modulation, repair and remodeling by splice switching oligonucleotidesRyszard Kole, Tiffany Williams, Lisa Cohen
Oligonucleotides|January 8, 2009
Therapeutic potential of splice-switching oligonucleotidesJohn Bauman, Natee Jearawiriyapaisarn, Ryszard Kole
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|August 20, 2003
Therapeutic potential of antisense oligonucleotides as modulators of alternative splicingPeter Sazani, Ryszard Kole
Oligonucleotides|June 13, 2006
Analysis of prostate-specific membrane antigen splice variants in LNCap cellsTiffany Williams, Ryszard Kole
Bioengineered Bugs|June 4, 2011
Modulation of RNA splicing as a potential treatment for cancerJohn A Bauman, Ryszard Kole
Advanced Drug Delivery Reviews|May 19, 2015
Exon skipping therapy for Duchenne muscular dystrophyRyszard Kole, Arthur M Krieg
Discovery Medicine|August 1, 2012
Targeting mRNA splicing as a potential treatment for Duchenne muscular dystrophyRyszard Kole, Brian J Leppert
Biochimica Et Biophysica Acta|June 27, 2002
Control of alternative splicing by antisense oligonucleotides as a potential chemotherapy: effects on gene expressionDanielle R Mercatante, Ryszard Kole
Oligonucleotides|April 24, 2004
Modification of alternative splicing by antisense therapeuticsRyszard Kole, Marla Vacek, Tiffany Williams
International Journal of Cancer|November 28, 2008
Modification of HER2 pre-mRNA alternative splicing and its effects on breast cancer cellsJing Wan, Peter Sazani, Ryszard Kole
Acta Biochimica Polonica|June 26, 2004
RNA modulation, repair and remodeling by splice switching oligonucleotidesRyszard Kole, Tiffany Williams, Lisa Cohen
Oligonucleotides|January 8, 2009
Therapeutic potential of splice-switching oligonucleotidesJohn Bauman, Natee Jearawiriyapaisarn, Ryszard Kole
Pageof 5